Trial Profile
Real-world experience from the TRIO network assessing Utilization of sofosbuvir/velpatasvir in genotype 2 – 6 HCV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Jul 2017 New trial record